Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for NTM (MABSC)
NCT03208764Phase 2Completed
- Sponsor
- Beyond Air
- Start
- Jul 2017
- Primary completion
- May 2018
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in Mycobacterium abscessus infection, sponsored by Beyond Air. Started Jul 2017; status: completed.
02
Drugs
nitric oxide
03
Conditions
Mycobacterium abscessus infection
Beyond the preview
Go deeper on NCT03208764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208764.